Comparison

EGFR-IN-63 European Partner

Item no. HY-147967-1ea
Manufacturer MedChem Express
CASRN 2414635-72-4
Amount 1 ea
Category
Type Chemicals
Specific against other
Formula C20H12BrN5S
Citations [1]Heba Abdelrasheed Allam, et al, Design and Synthesis of some new 2,4,6-trisubstituted quinazoline EGFR inhibitors as targeted anticancer agents, Bioorg Chem. 2020 May;98:103726
Smiles BrC1=CC2=C(NC3=NC4=CC=CC=C4S3)N=C(C5=CC=CN=C5)N=C2C=C1
ECLASS 5.1 32160000
ECLASS 6.1 32160000
ECLASS 8.0 32160000
ECLASS 9.0 32160000
ECLASS 10.0.1 32160000
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Available
Product Description
EGFR-IN-63 is an EGFR inhibition (IC50: 0.096 μM) and it has anticancer activity in MCF-7 cells (IC50: 2.49 μM).
Shipping
Room temperature
Manufacturers Applications
Cancer-Kinase/protease
MolecularWeight
434.31
Clinical_Information
No Development Reported
Manufacturers Research_Area
Cancer
Solubility
10 mM in DMSO
Pathway
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close